What is Modafinil 100mg used for?

In the pharmaceutical industry, Modafinil 100 mg is classified as a eugeroic or “wakefulness-promoting agent.” As a pharmacist, I categorize this as a unique Central Nervous System (CNS) stimulant; unlike traditional amphetamines or methylphenidate, Modafinil has a lower potential for abuse and does not typically cause the “crash” or intense jitteriness associated with older stimulants.

Primary Clinical Uses

  • Narcolepsy: The gold standard for treating excessive daytime sleepiness associated with narcolepsy.

  • Shift Work Sleep Disorder (SWSD): Prescribed for individuals whose work schedules interfere with normal sleep patterns, helping them stay alert during their shift.

  • Obstructive Sleep Apnea (OSA): Used as an adjunctive therapy when excessive sleepiness persists despite successful use of a CPAP machine.

  • Off-label/Cognitive Enhancement: Widely used as a “nootropic” to improve focus, memory, and productivity in high-pressure environments.

Mechanism of Action: Selective Dopamine Inhibition

While the exact mechanism is complex and multi-faceted, Modafinil is known to work differently than standard stimulants.

DAT Inhibition: It acts as a selective, relatively weak Dopamine Transporter (DAT) inhibitor. By blocking the reuptake of dopamine, it increases extracellular dopamine levels in specific brain regions related to alertness.

Orexin/Hypocretin System: It is believed to activate the orexin system in the hypothalamus, which is the body’s natural “on/off” switch for wakefulness.

GABA/Glutamate Balance: It modulates the levels of Gamma-Aminobutyric Acid (GABA) and Glutamate, leading to heightened alertness without the heavy peripheral “fight or flight” response seen with caffeine.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Modafinil 100 mg is a high-value “lifestyle” and “specialty” pharmaceutical:

  • BCS Class II Challenges: Modafinil is practically insoluble in water. At our WHO-GMP facility, we focus on micronization of the API and the use of specific surfactants to ensure the 100 mg tablet meets strict BP/USP/IP dissolution standards.

  • Abuse Potential Management: While it is a Schedule IV controlled substance in many markets (like the USA), its low abuse potential makes it a very attractive product for international B2B trading compared to Schedule II stimulants.

  • Stability for Export: We utilize Alu-Alu blister packaging to protect the API from moisture and light, ensuring a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: Our Mumbai-based facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Provigil).

What is Metronidazole 250 mg used for?

In the pharmaceutical industry, Metronidazole 250 mg is a highly effective nitroimidazole antimicrobial. As a pharmacist and manufacturer, I classify this molecule as a “dual-threat” agent because it possesses both potent antibacterial properties against anaerobes and significant antiprotozoal activity.

Primary Clinical Uses

  • Amoebiasis & Giardiasis: Treatment of intestinal and extra-intestinal infections caused by Entamoeba histolytica and Giardia lamblia.

  • Trichomoniasis: A first-line treatment for this common parasitic sexually transmitted infection (STI).

  • Anaerobic Bacterial Infections: Used for intra-abdominal infections, skin/skin structure infections, and bone/joint infections caused by Gram-negative anaerobic bacilli like Bacteroides fragilis.

  • Dental Infections: Highly effective for acute dental abscesses, infected gums (ANUG), and pericoronitis.

  • H. pylori Eradication: Often part of a “triple therapy” regimen to treat stomach ulcers.

  • Bacterial Vaginosis: A standard treatment for resolving vaginal flora imbalances.

Mechanism of Action: DNA Fragmentation

Metronidazole is a prodrug that is selectively activated within the target organism.

  1. Selective Reduction: The nitro group of Metronidazole is reduced by the electron transport proteins (like ferredoxin) found only in anaerobic organisms.

  2. Formation of Reactive Radicals: This reduction creates highly unstable, short-lived toxic intermediate compounds and free radicals.

  3. DNA Disruption: These radicals attack the microbial DNA, causing strand breakage and loss of helical structure.

  4. Bactericidal Effect: The damage to the DNA inhibits nucleic acid synthesis, leading to rapid cell death of the pathogen.

The Manufacturer’s Perspective: Technical & Export

From a production and global trade standpoint, Metronidazole 250 mg is a high-volume “Essential Medicine”:

  • The “Metallic Taste” Challenge: Metronidazole has a distinctively bitter, metallic taste. As a WHO-GMP manufacturer, we often utilize specialized film-coating to mask this taste, improving patient compliance—a major selling point for your B2B clients.

  • Drug-Alcohol Interaction: As a pharmacist, you know the importance of the Disulfiram-like reaction. We ensure our Product Information Leaflet (PIL) and packaging carry clear warnings against alcohol consumption during treatment.

  • Stability for Global Trade: Metronidazole is relatively stable but light-sensitive. At our Mumbai facility, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • B2B & Dossier Support: This is a staple for general practitioners and dental clinics. We provide full CTD/eCTD Dossiers to support international registration against the innovator (Flagyl).

 

What is Metronidazole 200mg tablets used for?

In the pharmaceutical industry, Metronidazole 200 mg is a highly effective nitroimidazole antimicrobial. As a pharmacist and manufacturer, I classify this as a “dual-threat” medication because it acts as both a potent antibacterial and an antiprotozoal agent. It is specifically designed to target anaerobic organisms—bacteria that thrive in environments without oxygen.

Primary Clinical Uses

  • Amoebiasis and Giardiasis: Treatment of intestinal infections caused by protozoa, often resulting from contaminated food or water.

  • Trichomoniasis: A common sexually transmitted infection (STI).

  • Dental Infections: Used for acute periapical abscesses and gingivitis (specifically Vincent’s Angina).

  • Bacterial Vaginosis: Clearing infections caused by an overgrowth of anaerobic bacteria.

  • Post-Operative Prophylaxis: Used during abdominal or gynecological surgeries to prevent infections from anaerobic gut bacteria.

  • H. pylori Eradication: Often part of a triple-therapy regimen for treating stomach ulcers.

Mechanism of Action: The Free Radical Attack

Metronidazole is a prodrug that is only activated within the anaerobic cell.

elective Reduction: The nitro group of Metronidazole is reduced by the electron transport proteins (like ferredoxin) found only in anaerobic organisms.

DNA Fragmentation: This reduction creates highly reactive short-lived free radicals.

Cell Death: These radicals attack the microbial DNA, causing strand breakage and inhibiting nucleic acid synthesis, which leads to rapid cell death. Because aerobic cells (like human cells) lack these specific transport proteins, they are largely unaffected.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Metronidazole 200 mg is a high-volume essential medicine:

  • The “Metallic Taste” Challenge: Metronidazole is notoriously bitter. As a WHO-GMP manufacturer, we focus on high-quality film-coating to mask the taste, which significantly improves patient compliance—a major selling point for your B2B export clients.

  • Dosage Flexibility: While 400 mg is common, the 200 mg strength is vital for pediatric dosing and for specific titration in elderly patients or those with hepatic impairment.

  • Stability for Tropical Export: Metronidazole is light-sensitive. At our Mumbai-based facility, we utilize Amber-colored PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • B2B & Public Health Tenders: This is a core item for the WHO Model List of Essential Medicines. We provide full CTD/eCTD Dossiers to support international registration against the innovator (Flagyl).

What are Metoprolol Tartrate 50 mg tablets used for?

In the pharmaceutical industry, Metoprolol Tartrate 50 mg is a classic selective beta-blocker targeting the -adrenergic receptors. As a pharmacist and manufacturer, I classify this as an “immediate-release” cardioselective agent. While its brother, Metoprolol Succinate, is designed for 24-hour extended release, the Tartrate version is typically administered twice daily for rapid and precise control of heart rate and blood pressure.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used to lower blood pressure, thereby reducing the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Angina Pectoris: Used for the long-term prophylaxis of chest pain by reducing the oxygen demand of the heart.

  • Post-Myocardial Infarction: Administered to stable patients after a heart attack to reduce cardiovascular mortality.

  • Arrhythmias: Effective in controlling ventricular rate in patients with atrial fibrillation or supraventricular tachycardia.

  • Migraine Prophylaxis (Off-label): Frequently prescribed to reduce the frequency and severity of migraine attacks.

Mechanism of Action:  Selectivity

Metoprolol Tartrate works by competing with adrenergic neurotransmitters (like adrenaline) for binding sites.

Selective Blockade: At standard doses (like 50 mg), it preferentially blocks  receptors located chiefly in the heart muscle.

Negative Inotropic & Chronotropic Effects: It decreases the heart rate (chronotropic) and the force of contraction (inotropic).

Cardiac Output: By slowing the heart and reducing the force, it lowers cardiac output and blood pressure, giving the heart a “rest.”

Renin Inhibition: It also reduces the release of renin from the kidneys, further interfering with the blood-pressure-raising RAAS pathway.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Metoprolol Tartrate 50 mg is a high-volume cardiovascular staple:

  • Tartrate vs. Succinate (The USP): On your digital platforms, it is vital to distinguish between the two. Tartrate is Immediate Release (IR), while Succinate is Extended Release (ER/XL). B2B buyers often look for Tartrate for acute hospital settings or specific twice-a-day titration needs.

  • Scored Tablets: Most 50 mg tablets are produced with a break-line (score). As a WHO-GMP manufacturer, we ensure “Content Uniformity” across the score line, allowing patients to accurately split the tablet into two 25 mg doses if prescribed.

  • Stability & Sensitivity: Metoprolol is sensitive to light and moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: Our Mumbai facility provides full CTD/eCTD Dossiers and bioequivalence data against the innovator (Lopressor) to support your firm’s international registrations.

What is Metoclopramide 10mg used for?

In the pharmaceutical industry, Metoclopramide 10 mg is a potent dopamine  receptor antagonist and prokinetic agent. As a pharmacist and manufacturer, I classify this as a “pro-motility” drug. It is a dual-action molecule that works both centrally (in the brain) and peripherally (in the gut) to speed up digestion and suppress the urge to vomit.

Primary Clinical Uses

  • Nausea and Vomiting: Used to prevent or treat emesis induced by chemotherapy, radiation therapy, surgery, or acute migraines.

  • Gastroesophageal Reflux Disease (GERD): Prescribed for patients who do not respond to standard acid-suppressing therapy; it helps by strengthening the lower esophageal sphincter.

  • Diabetic Gastroparesis: A vital treatment for “stomach paralysis” in diabetic patients, where it stimulates the stomach to empty more quickly into the intestines.

  • Facilitation of Intubation: Used in hospital settings to help clear the stomach before small bowel intubation or radiological examinations.

Mechanism of Action: The Dual Pathway

Metoclopramide exerts its effect through two primary neurotransmitter pathways:

Dopamine  Antagonism: In the Chemoreceptor Trigger Zone (CTZ) of the brain, it blocks dopamine receptors. This directly inhibits the signal that triggers nausea and vomiting.

Cholinergic Stimulation: In the upper gastrointestinal tract, it sensitizes tissues to acetylcholine.

The Result: It increases the tone and amplitude of gastric contractions, relaxes the pyloric sphincter, and increases peristalsis of the duodenum and jejunum.

The Manufacturer’s Perspective: Technical & Export

From a production standpoint at a WHO-GMP facility, Metoclopramide 10 mg requires careful professional oversight:

  • The “Fast-Track” USP: On your digital platforms, you can market Metoclopramide as a “prokinetic stabilizer.” It is a high-volume, cost-effective staple for any B2B pharmacy portfolio.

  • Photosensitivity: Metoclopramide is sensitive to light. As a firm owner, you know that the API can degrade if exposed. We utilize Amber-colored PVC or Alu-Alu blister packaging to maintain a 36-month shelf life for export to Zone IVb regions.

  • Safety & Regulatory Compliance: Metoclopramide carries a “Black Box Warning” for Tardive Dyskinesia (involuntary movements) if used for more than 12 weeks. Your Product Information Leaflet (PIL) and website content must reflect these safety guidelines to meet international regulatory standards.

    Dossier Support: Our Mumbai-based facility provides full CTD/eCTD Dossiers and dissolution profiles against the innovator (Reglan) to support your firm’s international registration efforts.

What is Methylprednisolone 4 mg used for?

In the pharmaceutical industry, Methylprednisolone 4 mg is a highly potent synthetic glucocorticoid (corticosteroid). As a pharmacist and manufacturer, I view the 4 mg strength as a precision dosage, often used in a “Medrol Dosepak” style tapering regimen to treat acute inflammatory flare-ups while minimizing the risk of systemic steroid side effects.

Primary Clinical Uses

  • Endocrine Disorders: Used for primary or secondary adrenocortical insufficiency.

  • Rheumatic Disorders: Short-term management of acute episodes or exacerbations in rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis.

  • Allergic Conditions: Control of severe or incapacitating allergic conditions such as bronchial asthma, contact dermatitis, and drug hypersensitivity reactions.

  • Dermatologic Diseases: Treatment of severe conditions like Pemphigus, Stevens-Johnson syndrome, and severe psoriasis.

  • Autoimmune Diseases: Management of systemic lupus erythematosus (SLE) and acute rheumatic carditis.

Mechanism of Action: Genomic & Non-Genomic Pathways

Methylprednisolone is roughly 5 times more potent than hydrocortisone. It works by diffusing across cell membranes to bind with high affinity to specific cytoplasmic receptors.

  1. Anti-Inflammatory Action: It inhibits the production of inflammatory mediators, including prostaglandins and leukotrienes, by inducing lipocortins which inhibit phospholipase $A_2$.

  2. Immunosuppression: It reduces the activity and volume of the lymphatic system, causing a decrease in lymphocyte and antibody concentrations.

  3. Protein Synthesis Modulation: The steroid-receptor complex moves into the nucleus, binding to DNA and altering gene transcription to stop the “cytokine storm” associated with severe inflammation.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Methylprednisolone 4 mg is a high-value specialty product:

  • Tapering Dosing (Dosepak): As a manufacturer, we often package these in specialized 21-tablet blisters designed for a 6-day tapering schedule. Providing this specific packaging format is a major USP (Unique Selling Proposition) for your export clients.

  • API Stability: Methylprednisolone is sensitive to light and moisture. At our WHO-GMP facility in Mumbai, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for maintaining potency in Zone IVb regions.

  • Low Dose Uniformity: Achieving a precise 4 mg distribution in a tablet requires high-shear granulation and validated blending protocols to meet BP/USP/IP assay requirements.

  • Regulatory Compliance: This is a “Schedule H” drug in India and a prescription-only medicine globally. Our facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Medrol).

 

 

What is Metformin Sustained release 500 mg used for?

In the pharmaceutical industry, Metformin Sustained Release (SR) 500 mg (also known as Extended-Release or ER) is a specialized formulation of the first-line biguanide used for Type 2 Diabetes Mellitus.

As a pharmacist, I classify the SR 500 mg tablet as a “compliance booster.” While the active molecule is the same as the immediate-release (IR) version, the Sustained Release technology is designed to release the medication slowly over 24 hours. This addresses the primary barrier to Metformin therapy: gastrointestinal (GI) side effects.

Primary Clinical Uses

  • Type 2 Diabetes Management: Used as an adjunct to diet and exercise to lower blood glucose. It is particularly effective at reducing Fasting Plasma Glucose (FPG).

  • Insulin Resistance & Prediabetes: Often the only recommended pharmacological intervention to prevent the progression of prediabetes to full-blown Type 2 diabetes.

  • PCOS (Polycystic Ovary Syndrome): Prescribed off-label to manage insulin resistance, aid in weight management, and help restore regular ovulation and fertility in women.

  • Patient Transition: Used for patients who cannot tolerate the nausea, bloating, or diarrhea commonly associated with Metformin IR 500 mg.

Mechanism of Action: The Dual-Polymer Matrix

From a manufacturing perspective, Metformin SR utilizes a dual hydrophilic polymer matrix system (often referred to as a “GEL” matrix).

Hydration: Upon ingestion, the tablet’s outer polymers hydrate and swell, forming a thick gel layer.

Diffusion: The Metformin is trapped in an “inner phase” and slowly diffuses through the “external phase” (the gel) into the GI tract at a steady rate.

Physiological Action: Like standard Metformin, it reduces hepatic glucose production, increases peripheral insulin sensitivity, and delays intestinal glucose absorption—but without the sudden “spike” in concentration that irritates the stomach.

The Manufacturer’s Perspective: Formulation & Export

As you develop your digital platforms and social media, highlighting the technical superiority of SR/ER technology is a major B2B selling point:

  • Tolerability Advantage: Clinical studies show that the incidence of GI adverse effects is significantly lower (up to 50% less) with SR formulations compared to IR. This leads to better patient retention and higher re-order rates for your trading firm.

  • Dosing Frequency: Metformin SR is typically taken once daily with the evening meal. For a multivendor marketplace, this “once-a-day” convenience makes it a preferred product for export to markets with busy urban populations.

  • Packaging & Stability: We utilize Alu-Alu blister packaging at our WHO-GMP facility. This protects the polymer matrix from moisture, which is critical; if the polymers absorb moisture during storage, the “sustained release” mechanism can fail (a phenomenon known as “dose dumping”).

  • Dossier Support: Our Mumbai facility provides full eCTD/CTD Dossiers for Metformin SR 500 mg, including Comparative Dissolution Profiles against the innovator (Glucophage XR) to ensure international regulatory approval.

What is Metformin 850 mg used for?

In the pharmaceutical industry, Metformin Hydrochloride 850 mg is considered the cornerstone of Type 2 Diabetes Mellitus (T2DM) management. As a pharmacist and manufacturer, I view the 850 mg strength as a high-potency “titration” dose. While many patients start on 500 mg, the 850 mg tablet is often used twice daily to achieve the maximum effective daily dose (approximately 1700 mg to 2550 mg) while maintaining a simpler pill count.

Primary Clinical Uses

  • Type 2 Diabetes Mellitus: The first-line pharmacological treatment for improving glycemic control, especially in overweight and obese patients.

  • Pre-diabetes: Used to delay or prevent the onset of full Type 2 diabetes in high-risk individuals.

  • Polycystic Ovary Syndrome (PCOS): Used off-label to improve insulin sensitivity, regulate menstrual cycles, and aid in fertility by lowering androgen levels.

  • Gestational Diabetes: Increasingly used during pregnancy when diet and exercise alone are insufficient.

    Mechanism of Action: The Insulin Sensitizer

Metformin is a Biguanide. Unlike sulfonylureas, it does not stimulate the pancreas to produce more insulin, which is why it carries a very low risk of hypoglycemia (low blood sugar).

Hepatic Glucose Inhibition: It primarily works in the liver to decrease gluconeogenesis (the production of glucose from non-carbohydrate sources).

Muscle Sensitivity: It increases the sensitivity of peripheral tissues (like skeletal muscle) to insulin, facilitating glucose uptake and utilization.

Intestinal Absorption: It slows down the absorption of glucose from the intestines into the bloodstream.

AMPK Activation: At the cellular level, it activates the AMP-activated protein kinase (AMPK), which plays a key role in energy metabolism.

The Manufacturer’s Perspective: Formulation & Export

Producing high-quality Metformin 850 mg in a WHO-GMP facility like yours involves specific technical challenges:

  • Tablet Size & Bulk: Metformin is a high-dose API. A 850 mg tablet is physically large. As a manufacturer, we optimize the choice of binders and fillers to keep the tablet size manageable for the patient (improving “swallowability”).

  • Immediate vs. Extended Release (ER/SR): While 850 mg is commonly an immediate-release format, we also manufacture SR (Sustained Release) versions. For your digital marketplace, offering both is key, as SR versions significantly reduce the common gastrointestinal side effects (bloating/diarrhea).

  • Solubility & Dissolution: Metformin is highly water-soluble (BCS Class I). We ensure the formulation meets strict BP/USP/IP dissolution profiles to guarantee consistent drug release and bioequivalence against the innovator (Glucophage).

  • Stability for Export: We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

What is Mefenamic Acid 500mg used for?

In the pharmaceutical industry, Mefenamic Acid 500 mg is a prominent Non-Steroidal Anti-Inflammatory Drug (NSAID) belonging to the fenamate class. As a pharmacist and manufacturer, I view Mefenamic Acid as a specialized analgesic particularly prized for its efficacy in gynecological and dental applications. It is often considered more effective than paracetamol for inflammatory and spasmodic pain.

Primary Clinical Uses

  • Dysmenorrhea (Period Pain): The most common indication. It reduces uterine contractions and the associated pain/cramps.

  • Menorrhagia: Used to reduce excessive menstrual blood loss (when organic pathology is ruled out).

  • Mild to Moderate Acute Pain: Effective for dental pain, post-operative pain, and musculoskeletal injuries.

  • Inflammatory Conditions: Symptomatic relief of Rheumatoid Arthritis (including Still’s Disease) and Osteoarthritis.

  • Headaches & Fever: Used for tension headaches and as an antipyretic to reduce high body temperature.

Mechanism of Action: The “Dual” Inhibitor

What makes Mefenamic Acid unique compared to other NSAIDs is its dual approach to managing pain:

Inhibition of Synthesis: Like most NSAIDs, it inhibits the COX-1 and COX-2 enzymes, preventing the formation of prostaglandins from arachidonic acid.

Receptor Blockade: Uniquely, Mefenamic Acid is also believed to block prostaglandin receptors that have already been formed. This makes it exceptionally effective for uterine pain, where prostaglandin levels are already high.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Mefenamic Acid 500 mg is a high-volume essential product:

  • Bioavailability Challenges: Mefenamic Acid is a BCS Class II drug (low solubility, high permeability). At our WHO-GMP facility, we focus on micronization of the API and the use of specific surfactants to ensure the 500 mg tablet meets the strict dissolution standards of BP/USP/IP.

  • Gastric Protection: Due to its high potential for GI irritation, we often recommend patients take it with food. As a manufacturer, we ensure our Product Information Leaflet (PIL) clearly highlights this.

  • Stability for Export: We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to protect the product from moisture, ensuring a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Dossier Support: This is a staple for women’s health distributors. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Ponstan).

What is Mebeverine Hydrochloride tablets used for?

In the pharmaceutical industry, Mebeverine Hydrochloride is a specialized musculotropic antispasmodic. As a pharmacist and manufacturer, I view Mebeverine as a “targeted” gastrointestinal drug because it acts directly on the smooth muscles of the gut without affecting the normal motility of the bowel or causing the “anticholinergic” side effects (like dry mouth or blurred vision) typical of older antispasmodics.

Primary Clinical Uses

  • Irritable Bowel Syndrome (IBS): The primary indication for the symptomatic relief of abdominal pain, cramps, persistent diarrhea, and flatulence associated with IBS.

  • Gastrointestinal Spasm: Used to treat spasms of the GI tract secondary to organic diseases like diverticulitis or regional enteritis.

  • Chronic Irritable Colon: Management of functional bowel disorders characterized by irregular bowel movements and pain.

Mechanism of Action: Direct Muscle Relaxation

Mebeverine works through a non-atropine-like mechanism, focusing specifically on the smooth muscle cells of the colon.

Ion Channel Modulation: It acts directly on the smooth muscle cells by inhibiting voltage-gated sodium channels and limiting the replenishment of intracellular calcium stores.

Spasmolysis: By preventing the influx of sodium and the release of calcium, it stops the muscle from over-contracting (spasming).

Preserved Motility: Crucially, it does not interfere with the normal “peristalsis” (the wave-like movement that pushes food through), making it much more comfortable for long-term use than other antispasmodics.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Mebeverine is a high-demand product in the gastroenterology sector:

  • Sustained Release (SR) vs. IR: While the standard dose is 135 mg (Immediate Release), we often manufacture 200 mg SR Capsules. For your B2B marketplace, the 200 mg SR version is highly popular as it improves patient compliance to twice-daily dosing.

  • Stability & Coating: Mebeverine is stable but requires protection from humidity. At our WHO-GMP facility, we utilize film-coating for tablets to mask the bitter taste and Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Regulatory Compliance: We provide full CTD/eCTD Dossiers and bioequivalence data against the innovator (Colofac) to support registration in international markets.

  • Market Positioning: On your digital platforms, you can market this as a “Superior GI Antispasmodic” due to its lack of systemic side effects, which is a significant USP for B2B buyers.

Add to cart